Strome Group, Inc. files SEC Form 4 disclosures for Zivo Bioscience, Inc.. They have made 2 open-market trades across 1 company since 2017, most recently 2026-02-12.
CIK 0001724136
2 open-market purchases totalling $395K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZIVO | 472,942 | $520K |
Shares reported on the most recent Form 4, priced at the 2026-02-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.